Monographie - Ceftobiprole medocaril sodium

Poslední aktualizace :
16/12/2025

Ceftobiprole medocaril sodium

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adaluzis	Airija
Mabelio	Prancūzija
Zevtera	Didžioji Britanija, Ispanija, Meksikas, Norvegija, Peru, Suomija, Švedija, Šveicarija, Vokietija

Bibliografija : Ceftobiprole medocaril sodium

	tipas	leidinys
2269	Žurnalas	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3520	Laboratorija	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3549	Laboratorija	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratorija	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratorija	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4650	Laboratorija	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
5098	Žurnalas	Esteban‑Cartelle B, Anaya B.J, Menéndez‑Conde C.P, Vicente‑Oliveros N , Serrano D.R, Álvarez‑Díaz A. Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices. Infect Dis Ther 2025 ; 14:1685–1696.

Mentions Légales